Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?

Martinez, A., Gil, C., & Perez, D. I. (2011). Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment. International Journal of Alzheimer＇s Disease, 2011(), 257-263. https://doi.org/10.4061/2011/280502
Rodríguez, S. M., Perry, G., Zhu, X., I.Moreira, P., & Williams, S. (2012). Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?. International Journal of Alzheimer＇s Disease, 2012(), 176-179. https://doi.org/10.1155/2012/276803
黃鉦翔、林志信、李承榆、簡虹琪、陳廷碩、李琦玫、李桂楨（2013）。Therapeutic Strategy Targeting Amyloid-β Aggregation for Alzheimer's Disease。Bio Formosa，48()，55-62。https://doi.org/10.6248/BF.2013.48.07
Mehta, M., Adem, A., & Sabbagh, M. (2012). New Acetylcholinesterase Inhibitors for Alzheimer's Disease. International Journal of Alzheimer＇s Disease, 2012(), 765-772. https://doi.org/10.1155/2012/728983
Koh, S. H., Baek, W., & Kim, S. H. (2011). Brief Review of the Role of Glycogen Synthase Kinase-3β in Amyotrophic Lateral Sclerosis. Neurology Research International, 2011(), 42-46. https://doi.org/10.1155/2011/205761